Episurf Medical AB (OSTO:EPIS B) FCF Margin % : -555.88% (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Episurf Medical AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Episurf Medical AB's Free Cash Flow for the three months ended in Sep. 2024 was kr-18.90 Mil. Episurf Medical AB's Revenue for the three months ended in Sep. 2024 was kr3.40 Mil. Therefore, Episurf Medical AB's FCF Margin % for the quarter that ended in Sep. 2024 was -555.88%.

As of today, Episurf Medical AB's current FCF Yield % is -79.07%.

The historical rank and industry rank for Episurf Medical AB's FCF Margin % or its related term are showing as below:

OSTO:EPIS B' s FCF Margin % Range Over the Past 10 Years
Min: -19958.96 Med: -1435.21 Max: -677.78
Current: -677.78

During the past 13 years, the highest FCF Margin % of Episurf Medical AB was -677.78%. The lowest was -19958.96%. And the median was -1435.21%.

OSTO:EPIS B's FCF Margin % is ranked worse than
91.54% of 827 companies
in the Medical Devices & Instruments industry
Industry Median: -5.37 vs OSTO:EPIS B: -677.78

Episurf Medical AB FCF Margin % Historical Data

The historical data trend for Episurf Medical AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Episurf Medical AB FCF Margin % Chart

Episurf Medical AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,320.41

-1,174.00

-1,026.15

-1,224.24

-915.53

Episurf Medical AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-980.77	-755.17	-748.39	-668.75	-555.88

Competitive Comparison of Episurf Medical AB's FCF Margin %

For the Medical Devices subindustry, Episurf Medical AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Episurf Medical AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Episurf Medical AB's FCF Margin % falls into.

Episurf Medical AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Episurf Medical AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-94.3	/	10.3
	=	-915.53 %

Episurf Medical AB's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-18.9	/	3.4
	=	-555.88 %

Episurf Medical AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Episurf Medical AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Episurf Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Episurf Medical AB (OSTO:EPIS B) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

0QUT:UK 16E:Germany

Address

Karlavagen 60, Stockholm, SWE, 114 49

Website

https://www.episurf.com

Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy.

Episurf Medical AB Headlines

No Headlines